COLL COLLEGIUM PHARMACEUTICAL INC Management Changes 8-K Filing 2025 - Appointments On May 15, 2025, Collegium Pharmaceutical held its Annual Meeting where shareholders approved the 2025 Equity Incentive Plan, elected eight directors for the next year, and ratified Deloitte as their independent auditor. A total of 29,094,522 shares voted at the meeting, out of 32,131,798 entitled to vote.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC